Show simple item record

dc.contributor.authorGorecka, Miroslawa
dc.contributor.authorMcCann, Gerry P
dc.contributor.authorBerry, Colin
dc.contributor.authorFerreira, Vanessa M
dc.contributor.authorMoon, James C
dc.contributor.authorMiller, Christopher A
dc.contributor.authorChiribiri, Amedeo
dc.contributor.authorPrasad, Sanjay
dc.contributor.authorDweck, Marc R
dc.contributor.authorBucciarelli-Ducci, Chiara
dc.contributor.authorDawson, Dana
dc.contributor.authorFontana, Marianna
dc.contributor.authorMacfarlane, Peter W
dc.contributor.authorMcConnachie, Alex
dc.contributor.authorNeubauer, Stefan
dc.contributor.authorGreenwood, John P
dc.contributor.authorCOVID-HEART investigators
dc.date.accessioned2021-06-18T21:21:01Z
dc.date.available2021-06-18T21:21:01Z
dc.date.issued2021-06-10
dc.identifier.citationGorecka , M , McCann , G P , Berry , C , Ferreira , V M , Moon , J C , Miller , C A , Chiribiri , A , Prasad , S , Dweck , M R , Bucciarelli-Ducci , C , Dawson , D , Fontana , M , Macfarlane , P W , McConnachie , A , Neubauer , S , Greenwood , J P & COVID-HEART investigators 2021 , ' Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19 : protocol design of COVID-HEART-a UK, multicentre, observational study ' , Journal of Cardiovascular Magnetic Resonance , vol. 23 , no. 1 , 77 . https://doi.org/10.1186/s12968-021-00752-1en
dc.identifier.issn1097-6647
dc.identifier.otherPURE: 195487714
dc.identifier.otherPURE UUID: 6171cdec-4e96-4b8c-bad8-4f757819f152
dc.identifier.otherPubMed: 34112195
dc.identifier.otherPubMedCentral: PMC8190746
dc.identifier.otherScopus: 85107793056
dc.identifier.otherWOS: 000660031200001
dc.identifier.urihttps://hdl.handle.net/2164/16699
dc.descriptionAcknowledgements CB acknowledges British Heart Foundation support (RE/18/6134217). GPM is funded by a NIHR Research Professorship (RP‐2017‐08‐ST2‐007). CM is funded by a NIHR Clinician Scientist Award (CS‐2015‐15‐003). VMF and SN acknowledge the NIHR Oxford BRC for support of this study. CBD is in part supported by the NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol. Additional support was provided by the NIHR Leicester Biomedical Research Centre and the NIHR Leeds Clinical Research Facility. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care. We thank the patients and staff who have supported this project. Dr. Warren J. Manning served as a Guest Editor for this manuscript. Study Management and Recruitment centres: Grant applicants: JP Greenwood (chief investiga‐ tor), GP McCann, C Berry, M Dweck, J Moon, CM Miller, A Chiribiri, S Prasad, VM Ferreira, C Bucciarelli‐Ducci, D Dawson. Data repository and statistical analysis: Glasgow Clinical Trials Unit. Senior study statistician: Prof A McConnachie, GCTU. Local Principle Investigators and Recruitment Centres: Prof John Green‐ wood, Leeds Teaching Hospitals NHS Trust, UK; Prof Gerry McCann, Glenfield Hospital, Leicester, UK; Prof Dana Dawson, Aberdeen Royal Infirmary, UK; Prof Marc Dweck, Royal Infirmary of Edinburgh, UK; Prof Vanessa Ferreira, JohnRadcliffe Hospital, Oxford, UK; Prof Colin Berry, Queen Elizabeth University Hospital, Glasgow, UK; Dr Peter Swoboda, Pinderfields Hospital, Wakefield, UK; Dr Richard Steeds, Queen Elizabeth Hospital, Birmingham, UK; Prof James Moon, UCL Hospital London, UK; Dr Christopher Miller, Wythenshawe Hospital, Manchester, UK; Dr Timothy Fairbairn, Liverpool Heart and Chest Hospital, UK; Dr Andrew Flett, Southampton General Hospital, UK; Prof Marianna Fontana, Royal Free Hospital, London, UK; Dr Thomas Green, Northumbria NHS Trust, UK; Prof Amedeo Chiribiri, St Thomas’ Hospital, London, UK; Dr Chiara Bucciarelli‐Ducci, University Hospitals Bristol and Weston NHS Trust, UK; Dr Graham Cole, Hammersmith Hospital, London, UK; Prof Sanjay Prasad, Royal Brompton Hospital, London, UK; Dr Adam McDiarmid, Freeman Hospital, New‐ castle Upon Tyne, UK; Dr Nicholas Bunce, St Georges Hospital, London, UK; Dr Prathap Kanagala, Aintree University Hospital, Liverpool, UK; Prof Nicholas Bellenger, The Royal Devon and Exeter Hospital, UK; Dr Tishi Ninan, Swansea Bay University Hospital, UK; Dr Khaled Alfakih, Lewisham University Hospital, London, UK; Prof James Moon, St Bartholomew’s Hospital, London, UK. Funding COVID‐HEART is funded by the National Institute for Health Research (NIHR) and UK Research and Innovation (UKRI) COVID‐19 Rapid Response Rolling Call (Grant Number COV0254), and sponsored by the University of Leeds, UK. The study has been endorsed by the British Society of Cardiovascular Magnetic Resonance (BSCMR) Research Group, and nationally prioritised, and received both BHF‐NIHR Cardiovascular Partnership Flagship Status, and the NIHR Urgent Public Health Group identified it as an Urgent Public Health (UPH) study. Funding for the translation of the patient information leaflets into non‐ English languages was provided by the West Yorkshire and Humber Clinical Research Network (CV070).en
dc.format.extent13
dc.language.isoeng
dc.relation.ispartofJournal of Cardiovascular Magnetic Resonanceen
dc.rightsThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectCOVID‐19en
dc.subjectCoronavirusen
dc.subjectCardiovascular magnetic resonanceen
dc.subjectMyocarditisen
dc.subjectMyopericarditisen
dc.subjectMyocardial infarctionen
dc.subjectmyocardial injuryen
dc.subjectMyocardial inflammationen
dc.subjectMyocardial repairen
dc.subjectCardiovascular diseaseen
dc.subjectR Medicineen
dc.subjectNational Institute for Health Research (NIHR)en
dc.subjectRP‐2017‐08‐ST2‐007en
dc.subjectCS‐2015‐15‐003en
dc.subjectBritish Heart Foundationen
dc.subjectRE/18/6134217en
dc.subject.lccRen
dc.titleDemographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19 : protocol design of COVID-HEART-a UK, multicentre, observational studyen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciences - Cardiovascular Groupen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1186/s12968-021-00752-1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record